Inventor · disambiguated record
Kurt Gordon Pike
Also filed as: PIKE KURT · PIKE KURT G · PIKE KURT GORDON
22 granted patents·25 pending applications·88 citations·filing 2004–2023
94Inventor score
Files withASTRAZENECA AB34JOHNSTONE CRAIG6CAULKETT PETER WILLIAM RODNEY3MCKERRECHER DARREN2DISHINGTON ALLAN PAUL1
Top patents by PatentIndex Score
47 records- 0194US7745475B2Heteroaryl benzamide derivatives as GLK activatorsASTRAZENECA AB·Filed 2005·Granted Jun 29, 2010·14 cites·3 claims
- 0293US7642259B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2006·Granted Jan 5, 2010·18 cites·3 claims
- 0392US7642263B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Jan 5, 2010·16 cites·3 claims
- 0490US7842694B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Nov 30, 2010·11 cites·3 claims
- 0588US7671060B2Heteroaryl benzamide derivativesASTRAZENECA AB·Filed 2007·Granted Mar 2, 2010·13 cites·3 claims
- 0685US10457679B2Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerASTRAZENECA AB·Filed 2017·Granted Oct 29, 2019·3 cites·20 claims
- 0785US9856255B2Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerASTRAZENECA AB·Filed 2016·Granted Jan 2, 2018·3 cites·6 claims
- 0881US2023286981A1Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating CancerASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0978US10882858B2Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerASTRAZENECA AB·Filed 2019·Granted Jan 5, 2021·0 cites·4 claims
- 1074US11613539B2Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerASTRAZENECA AB·Filed 2020·Granted Mar 28, 2023·0 cites·9 claims
- 1174US9845331B2Chemical compoundsASTRAZENECA AB·Filed 2016·Granted Dec 19, 2017·1 cites·8 claims
- 1274US7750003B2Compounds-943ASTRAZENECA AB·Filed 2007·Granted Jul 6, 2010·2 cites·39 claims
- 1373US7902200B2Chemical compoundsASTRAZENECA AB·Filed 2007·Granted Mar 8, 2011·4 cites·9 claims
- 1473US2022340592A1Chemical compoundsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1571US8138183B2Morpholino pyrimidine derivatives used in diseases linked to mTOR kinase and/or PI3KPIKE KURT GORDON·Filed 2008·Granted Mar 20, 2012·3 cites·12 claims
- 1668US11352369B2Pyridine and pyrimidine derivativesASTRAZENECA AB·Filed 2020·Granted Jun 7, 2022·0 cites·19 claims
- 1765US7977328B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2008·Granted Jul 12, 2011·0 cites·12 claims
- 1865US2021347775A1Deuterated Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating CancerASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 1964US7964725B2Heteroarylbenzamide derivatives for use in the treatment of diabetesASTRAZENECA AB·Filed 2009·Granted Jun 21, 2011·0 cites·1 claims
- 2063US10189834B2Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerASTRAZENECA AB·Filed 2017·Granted Jan 29, 2019·0 cites·16 claims
- 2162US2019185468A1Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating CancerASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 2261US10717746B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Jul 21, 2020·0 cites·6 claims
- 2359US2009253676A1Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of DiabetesASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2457US9428503B2Imidazo[4,5-c]quinolin-2-one compounds and their use in treating CancerASTRAZENECA AB·Filed 2015·Granted Aug 30, 2016·0 cites·3 claims
- 2556US12410187B2Fused tricyclic compounds useful as anticancer agentsASTRAZENECA AB·Filed 2020·Granted Sep 9, 2025·0 cites·5 claims
- 2656US2020087300A1Deuterated Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating CancerASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 2755US9822111B2Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerASTRAZENECA AB·Filed 2016·Granted Nov 21, 2017·0 cites·2 claims
- 2850US2010227858A1Trisubstituted pyrimidine derivatives for the treatment of proliferative diseasesASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2949US2009018134A1Compounds - 945ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 3049US2008280872A1Benzamide Derivatives and Their Use as Glucokinase Activating AgentsJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 3148US2009062351A1Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activatorsCAULKETT PETER WILLIAM RODNEY·Filed 2004·Application pending·0 cites
- 3247US2011053910A12 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetesMCKERRECHER DARREN·Filed 2006·Application pending·0 cites
- 3346US2007255062A1Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) ActivatorsJOHNSTONE CRAIG·Filed 2004·Application pending·0 cites
- 3446US2019099421A1Cinnolin-4-amine compounds and their use in treating cancerASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 3545US7943607B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2006·Granted May 17, 2011·0 cites·17 claims
- 3645US2008280874A1Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and ObesityJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 3745US2009018157A1Chemical compoundsJOHNSTONE CRAIG·Filed 2004·Application pending·0 cites
- 3844US2018318287A1Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating CancerASTRAZENECA AB·Filed 2016·Application pending·0 cites
- 3944US2008234273A1Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of DiabetesMCKERRECHER DARREN·Filed 2006·Application pending·0 cites
- 4044US2011059941A12-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulatorsCAULKETT PETER WILLIAM RODNEY·Filed 2006·Application pending·0 cites
- 4144US2018280377A1Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating CancerASTRAZENECA AB·Filed 2016·Application pending·0 cites
- 4243US2011034432A1Benzamide derivatives and their use as glucokinase activating agentsASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 4342US2009105263A1Heterobicyclic compounds as glucokinase activatorsCAULKETT PETER WILLIAM RODNEY·Filed 2006·Application pending·0 cites
- 4441US2007287693A1Benzamide Derivatives That Act Upon The Glucokinase EnzymeJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 4541US2008312207A1CompoundsJOHNSTONE CRAIG·Filed 2005·Application pending·0 cites
- 4640US2019119270A1N-Oxide Compound and Its Use in Treating CancerASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 4737US2011034454A1Morpholino pyrimidine derivatives and their use in therapyDISHINGTON ALLAN PAUL·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →